AstraZeneca Pharma India Limited
NSE:ASTRAZEN.NS
Overview | Financials
Company Name | AstraZeneca Pharma India Limited |
Symbol | ASTRAZEN.NS |
Currency | INR |
Price | 7,306.8 |
Market Cap | 182,670,000,000 |
Dividend Yield | 0.29% |
52-week-range | 4,510 - 8,139 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Sanjeev Kumar Panchal |
Website | https://www.astrazeneca.in |
An error occurred while fetching data.
About AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD